Citation: Mk. Gould et Am. Garber, Cost-effectiveness of low-molecular-weight heparins for deep venous thrombosis - In response, ANN INT MED, 132(6), 2000, pp. 508-509
Citation: Ad. Brown et Am. Garber, Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing - Reply, J AM MED A, 282(15), 1999, pp. 1420-1420
Citation: Ad. Brown et Am. Garber, Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaoutesting, J AM MED A, 281(4), 1999, pp. 347-353
Citation: Sp. Chen et Am. Garber, Cost-effectiveness of methotrexate and Goeckerman therapy: A flawed analysis - In reply, ARCH DERMAT, 135(6), 1999, pp. 718-718
Citation: Am. Garber et Na. Solomon, Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease, ANN INT MED, 130(9), 1999, pp. 719
Authors:
Gould, MK
Dembitzer, AD
Sanders, GD
Garber, AM
Citation: Mk. Gould et al., Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis - A cost-effectiveness analysis, ANN INT MED, 130(10), 1999, pp. 789
Authors:
Gould, MK
Dembitzer, AD
Doyle, RL
Hastie, TJ
Garber, AM
Citation: Mk. Gould et al., Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis - A meta-analysis of randomized, controlled trials, ANN INT MED, 130(10), 1999, pp. 800